(Q51564935)
Statements
Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome. (English)
1 reference
Morris RS
1 reference
Karande VC
1 reference
Dudkiewicz A
1 reference
Morris JL
1 reference
Gleicher N
1 reference
1 March 1999
1 reference
71
1 reference
3
1 reference
452-456
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference